Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases

New data on COVID-19 Influenza combination vaccine and seasonal influenza vaccine to be presented at World Vaccine Congress Several abstracts and presentations slated to highlight updates on NVX-CoV2373, Novavax' COVID-19 vaccine GAITHERSBURG, Md., April 18, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, will provide...

Related Keywords

Mexico ,Portugal ,United States ,Lisbon ,Lisboa ,United Kingdom ,Washington ,Laura Keenan Lindsey ,Novavax Nanoflu ,Erika Schultz ,Gregorym Glenn ,Ali Chartan ,European Congress ,Linkedin ,World Vaccine Congress Washington ,World Health Organization ,European Commission ,Prnewswire Novavax Inc ,Nasdaq ,World Vaccine Congress ,Novavax Inc ,World Vaccine ,Clinical Microbiology ,Infectious Diseases ,Emergency Use ,World Health ,Keenan Lindsey ,